This study is designed as a retrospective, single center study. Up to 15 participants who had a transcrestal sinus elevation and implant placement using autogenous bone supporting an OSSIX Volumax collagen xenograft scaffolding will be enrolled. The study will include data collection from medical records and data collected at a follow up visit between January 2019 and March 2023.
The purpose of this study is to evaluate the outcome of transcrestal sinus elevation using autogenous bone supporting an OSSIX Volumax collagen scaffolding. Data to be collected includes demographics, past medical history including autoimmune diseases and connective tissue diseases, smoking history and known allergies. Implant data will be collected and change in crestal bone height will be measured radiographically and cone beam computed tomography at follow up. The protocol will include both single-staged and two-staged procedures. Adverse events will be collected and reported.
Study Type
OBSERVATIONAL
Enrollment
15
OSSIX Volumax is used in combination with autogenous bone collected during preparation of the implant osteotomy.
Old Orchard Periodontics and Implant Dentistry
Skokie, Illinois, United States
Change in crestal bone height
Measured radiographically and by cone beam computed tomography at follow up
Time frame: 4 months to 57 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.